| 臺大學術典藏 |
2018-09-10T05:48:07Z |
Republic of China: Status of cancer pain and palliative care
|
Sun, W.-Z.;Hou, W.-Y.;Li, J.-P.; WEI-ZEN SUN |
| 國立政治大學 |
2006 |
Republication: On the Selection of Adaptive Algorithms in ABM: A Computational-Equivalence Approach
|
Chen, Shu-heng;Tai, Chung-Ching; 陳樹衡 |
| 國立臺灣海洋大學 |
2004 |
Repulsive Force Control Based on Distance Computation Algorithm
|
Jih-Gau Juang |
| 淡江大學 |
2024-07-31T04:08:21Z |
Repurchase intention in a physical store: Moderated mediating role of electronic word-of-mouth
|
Liao, Shu-hsien;Fang, Yi-wen |
| 淡江大學 |
2023-01-31 |
Repurchase intention in a physical store: moderated mediating role of electronic word-of-mouth
|
Liao, Shu-Hsien;Hu, Da-Chian;Fang, Yi-Wen |
| 淡江大學 |
2023-02-03 |
Repurchase Intention in Physical Stores: A Moderated Mediating Role of Electronic Word-of-Mouth
|
Fang, SH. Liao* and Yi.W. |
| 亞洲大學 |
2017-08 |
Repurchase intention of Korean beauty products among Taiwanese consumers
|
Massoud Mosl;Massoud Moslehpour;黃永強;WONG,WING-KEUNG;Van Kien Pha;Van Kien Pham;Carrine K. A;Carrine K. Aulia; |
| 亞洲大學 |
2017 |
Repurchase intention of Korean beauty products among Taiwanese consumers
|
穆馬速;Moslehpour Massoud;黃永強;WONG-WING,KEUNG; |
| 國立成功大學 |
2023 |
Repurposing an integrated national influenza platform for genomic surveillance of SARS-CoV-2 in Ghana: a molecular epidemiological analysis
|
Asante, I.A.;Hsu, S.N.;Boatemaa, L.;Kwasah, L.;Adusei-Poku, M.;Odoom, J.K.;Awuku-Larbi, Y.;Foulkes, B.H.;Oliver-Commey, J.;Asiedu, E.K.;Parker, M.D.;Mitja, O.;Eggo, R.M.;de, Oliveira-Martins L.;Asiedu-Bekoe, F.;Laryea, D.O.;Kuma-Aboagye, P.;Marks, Marks M.;de, Silva T.I.;Ampofo, W.K. |
| 臺大學術典藏 |
2021-05-21T11:40:30Z |
Repurposing cabozantinib with therapeutic potential in KIT-driven t(8;21) acute myeloid leukaemias
|
Su, Kuan Wei; DA-LIANG OU; Fu, Yu Hsuan; HWEI-FANG TIEN; HSIN-AN HOU; LIANG-IN LIN |
| 臺大學術典藏 |
2022-01-12T07:07:10Z |
Repurposing cabozantinib with therapeutic potential in KIT-driven t(8;21) acute myeloid leukaemias
|
Su K.-W.; Ou D.-L.; Fu Y.-H.; Tien H.-F.; HSIN-AN HOU; Lin L.-I. |
| 臺大學術典藏 |
2022-01-25T06:01:28Z |
Repurposing cabozantinib with therapeutic potential in KIT-driven t(8;21) acute myeloid leukaemias
|
Su, Kuan-Wei; Ou, Da-Liang; Fu, Yu-Hsuan; HWEI-FANG TIEN; Hou, Hsin-An; Lin, Liang-In |
| 臺大學術典藏 |
2022-02-08T06:27:21Z |
Repurposing cabozantinib with therapeutic potential in KIT-driven t(8;21) acute myeloid leukaemias
|
Su K.-W.; DA-LIANG OU; Fu Y.-H.; Tien H.-F.; Hou H.-A.; Lin L.-I. |
| 臺大學術典藏 |
2021-07-06T01:53:04Z |
Repurposing cabozantinib with therapeutic potential in KIT-driven t(8;21) acute myeloid leukaemias
|
Su, Kuan-Wei; Ou, Da-Liang; Fu, Yu-Hsuan; Tien, Hwei-Fang; Hou, Hsin-An; LIANG-IN LIN |
| 國家衛生研究院 |
2025-01-21 |
Repurposing linezolid in conjunction with histone deacetylase inhibitor access in the realm of glioblastoma therapies
|
Chen, IC;Lin, HY;Liu, ZY;Cheng, WJ;Yeh, TY;Yang, WB;Tran, HY;Lai, MJ;Wang, CH;Kao, TY;Hung, CY;Huang, YL;Liou, KC;Hsieh, CM;Hsu, T;Liou, JP |
| 臺大學術典藏 |
2018 |
Repurposing Nilotinib for Cytomegalovirus Infection Prophylaxis after Allogeneic Hematopoietic Stem Cell Transplantation: A Single-Arm, Phase II Trial
|
Lin C.-T.; PO-REN HSUEH; Wu S.-J.; Yao M.; Ko B.-S.; Li C.-C.; Hsu C.-A.; Tang J.-L.; Tien H.-F.; Tien H.-F.;Tang J.-L.;Hsu C.-A.;Li C.-C.;Ko B.-S.;Yao M.;Wu S.-J.;PO-REN HSUEH;Lin C.-T. |
| 臺大學術典藏 |
2020-12-18T08:37:05Z |
Repurposing Nilotinib for Cytomegalovirus Infection Prophylaxis after Allogeneic Hematopoietic Stem Cell Transplantation: A Single-Arm, Phase II Trial
|
Ko B.-S.; Li C.-C.; Hsu C.-A.; Tang J.-L.; Tien H.-F.; Yao M.; Wu S.-J.; PO-REN HSUEH; Lin C.-T.; Lin C.-T.;Po-Ren Hsueh;Wu S.-J.;Yao M.;Ko B.-S.;Li C.-C.;Hsu C.-A.;Tang J.-L.;Tien H.-F. |
| 臺大學術典藏 |
2021-01-04T12:12:20Z |
Repurposing Nilotinib for Cytomegalovirus Infection Prophylaxis after Allogeneic Hematopoietic Stem Cell Transplantation: A Single-Arm, Phase II Trial
|
Tang J.-L.; HWEI-FANG TIEN; Li C.-C.; Hsu C.-A.; Ko B.-S.; Yao M.; Wu S.-J.; Lin C.-T.; Hsueh P.-R. |
| 臺大學術典藏 |
2018 |
Repurposing Nilotinib for Cytomegalovirus Infection Prophylaxis after Allogeneic Hematopoietic Stem Cell Transplantation: A Single-Arm, Phase II Trial
|
Li C.-C.; Ko B.-S.; Yao M.; SHANG-JU WU; Hsueh P.-R.; Lin C.-T.; Hsu C.-A.; Tang J.-L.; Tien H.-F. |
| 臺大學術典藏 |
2021-01-06T03:58:21Z |
Repurposing Nilotinib for Cytomegalovirus Infection Prophylaxis after Allogeneic Hematopoietic Stem Cell Transplantation: A Single-Arm, Phase II Trial
|
Lin C.-T.; Hsueh P.-R.; Wu S.-J.; Yao M.; Ko B.-S.; Li C.-C.; Hsu C.-A.; JIH-LUH TANG; Tien H.-F. |
| 臺大學術典藏 |
2018 |
Repurposing Nilotinib for Cytomegalovirus Infection Prophylaxis after Allogeneic Hematopoietic Stem Cell Transplantation: A Single-Arm, Phase II Trial
|
Lin C.-T.; Hsueh P.-R.; Wu S.-J.; MING YAO; Ko B.-S.; Li C.-C.; Hsu C.-A.; Tang J.-L.; Tien H.-F. |
| 國立成功大學 |
2023-01-14 |
Repurposing nitric oxide donating drugs in cancer therapy through immune modulation
|
Li;Chung-Yen;Anuraga;Gangga;Chang;Chih-Peng;Weng;Tzu-Yang;Hsu;Hui-Ping;Ta;Khoa, Hoang Dang;Su;Pei-Fang;Chiu;Pin-Hsuan;Yang;Shiang-Jie;Chen;Feng-Wei;Ye;Pei-Hsuan;Wang;Chih-Yang;Lai;Ming-Derg |
| 國立臺灣大學 |
2015 |
Repurposing of nitroxoline as a potential anticancer agent against human prostate cancer - a crucial role on AMPK/mTOR signaling pathway and the interplay with Chk2 activation
|
Chang, Wei-Ling; Hsu, Lih-Ching; Leu, Wohn-Jenn; Chen, Ching-Shih; Guh, Jih-Hwa; 許麗卿; 顧記華 |
| 臺大學術典藏 |
2021-06-02T05:43:35Z |
Repurposing of nitroxoline as a potential anticancer agent against human prostate cancer - A crucial role on AMPK/mTOR signaling pathway and the interplay with Chk2 activation
|
Chang W.-L.;Hsu L.-C.;Leu W.-J.;Chen C.-S.;Jih-Hwa Guh; Chang W.-L.; Hsu L.-C.; Leu W.-J.; Chen C.-S.; JIH-HWA GUH |
| 臺大學術典藏 |
2021-07-06T07:01:21Z |
Repurposing of nitroxoline as a potential anticancer agent against human prostate cancer - A crucial role on AMPK/mTOR signaling pathway and the interplay with Chk2 activation
|
Chang W.-L.; LIH-CHING HSU; Leu W.-J.; Chen C.-S.; Guh J.-H. |
